Generation of human iPSC line GRX-MCiPS4F-A2 from adult peripheral blood mononuclear cells (PBMCs) with Spanish genetic background  by Cabrera, Sonia et al.
Stem Cell Research 15 (2015) 337–340
Contents lists available at ScienceDirect
Stem Cell Research
j ourna l homepage: www.e lsev ie r .com/ locate /scrLab Resource: Stem Cell Line
Generation of human iPSC line GRX-MCiPS4F-A2 from adult peripheral blood
mononuclear cells (PBMCs) with Spanish genetic background
Sonia Cabrera a,1, Ae-Ri Ji a,b,1, Lidia Frejo a, Veronica Ramos-Mejia c, Tamara Romero c,
Pedro Real c, Jose A. Lopez-Escamez a,d
a Otology & Neurotology Group CTS495, Department of Genomic Medicine, GENYO — Centre for Genomics and Oncological Research — Pﬁzer/University of Granada/Junta de Andalucía, PTS,
Granada 18016 Spain
b Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan 330-714, Republic of Korea
c Gene regulation, Stem Cells and Development Group, Department of Genomic Oncology, GENYO — Centre for Genomics and Oncological Research — Pﬁzer/University of Granada/Junta de
Andalucía, PTS, Granada 18016 Spain
d Department of Otolaryngology, University of Granada Hospital, Granada, SpainIn
P
C
D
O
Ty
Su
K
A
Li
1 These authors contributed equally to this work.
http://dx.doi.org/10.1016/j.scr.2015.07.002
1873-5061/© 2015 The Authors. Published by Elsevier B.Va b s t r a c ta r t i c l e i n f oArticle history:
Received 9 July 2015
Accepted 13 July 2015
Available online 23 July 2015Wehave generated iPSCs fromperipheral bloodmononuclear cells (PBMCs) of a healthymanusing heat sensitive
and non-integrative Sendai virus containing Sox2, Oct3/4, c-Myc and Klf4. Human GRX-MCiPS4F-A2 cell line was
established and characterized through this study.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Resource Table: GRX-MCiPS4F-A2Name of Stem Cell construct CytoTune® 2.0 Sendai Reprogramming Kit (Life
Technologies)stitution Otology & Neurotology Group CTS495,
Department of Genomic Medicine, GENYO,
-Centre for Genomics and Oncological
Research– Pﬁzer/Universidad de Granada/
Junta de Andalucía, PTSerson who created resource Sonia Cabrera, Ae-Ri Ji
ontact person and email Sonia Cabrera, sonia.cabrera@genyo.es; Ae-Ri
Ji, aeri.ji@genyo.es
ate archived/stock date 20, June, 2015
rigin Healthy human male peripheral blood
mononuclear cells
pe of resource Biological reagent: induced pluripotent stem
cell (iPSC)
b-type Cell line
ey transcription factors Oct4, Sox2, cMyc, Klf4
uthentication Identity and purity of cell line conﬁrmed (Fig. 1)
nk to related literature (direct
URL links and full references)
formation in public databases NoIn. This is an open access article under1. Resource details
Heat sensitive Sendai virus containing Sox2, Oct3/4, c-Myc and Klf4
were used to generate human iPSC line GRX-MCiPS4F-A2. The exoge-
nous reprogramming factors were eliminated from the established
line at passage 7 (p7) in normal growth cultures.
To conﬁrm the pluripotency of GRX-MCiPS4F-A2, the expression of
several pluripotent markers were evaluated by RT-PCR, immunocyto-
chemistry, and FACS analyses. Endogenous expression of OCT4, SOX2,
KLF4, and NANOG were identiﬁed at mRNA level by RT-PCR. OCT4,
SSEA4, TRA-1-60, and Tra-1-81 proteinswere assessed by immunocyto-
chemistry and FACS analysis.
Moreover, GRX-MCiPS4F-A2 has shown normal karyotype (46, XY)
after 23 passages bymechanical transfers (Fig. 1). Differentiation capac-
ity into three germ layerswas demonstrated by in vitrodifferentiation of
embryoid bodies and teratoma formation in vivo (Fig. 2). GRX-MCiPS4F-
A2 cell line has been adapted to be cultured in feeder-free culture (on
Matrigel) and it has been maintained over 40 passages without mor-
phological alterations.
2. Materials and methods
2.1. Reprogramming lymphocytes to iPSCs
Blood samples were obtained from a healthy man with Spanish
genetic background, who gave written informed consent for the
generation of iPSCs. Mononuclear cells from peripheral blood werethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of human GRX-MCiPS4F-A2 line generated from peripheral blood mononuclear cells (PBMCs). (A) Established GRX-MCiPS4F-A2 line shows typical round shape
colony on the human foreskin ﬁbroblast feeder cells and strong alkaline phosphatase (AP) positive cells. (B) Exogenous reprogramming factors and Sendai virus vector (SeV) were
disappeared after several passages in GRX-MCiPS4F-A2, and the expression of endogenous pluripotent markers, OCT4, SOX2, KLF4, and Nanog, were conﬁrmed by RT-PCR.
(C, D) Representative data show the expression of pluripotent markers in protein levels by immounocytochemistry and FACS analysis. (E) GRX-MCiPS4F-A2 line shows normal karyotype
after long term cultures.
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Media, Biowest, France). Isolated mononuclear cells were cultured
for 4 days in PMBC media: StemSpan™ SFEM (StemCell Technolo-
gies Inc, Bâtiment Sirocco, France) supplemented with 100 ng/ml
hSCF, 100 ng/ml hFLT3L, 20 ng/ml hTPO, 10 ng/ml G-CSF and 2 ng/ml
hIL3 (GIBCO). Then, mononuclear cells were transferred to new cul-
ture plates and exposed to Sendai viral particles included in the
CytoTune cellular reprogramming kit (Invitrogen, San Diego, CA).
The next day, the CytoTune® 2.0 Sendai viral particles were re-
moved by centrifuging, and transduced cells were grown for
4 days in PMBC media. Then, cells were transferred on irradiated
human foreskin ﬁbroblast (iHFF, ATCC®CRL-2429) feeder cells in
human iPSC medium: KO-DMEM (Life Technology, CA, USA) supple-
mented with 20% knockout serum replacement (Fisher Scientiﬁc,
MA, USA), 8 ng/ml FGF2 (Miltenyl Biotec, Cologne, Germany),
10 μM Y-27632 (Deltaclon, Madrid, Spain), 1 mM glutamine (Fisher
Scientiﬁc), 1% MEM non-essential amino acids (Fisher Scientiﬁc)
and 0.1 mM 2-mercaptoethanol (Sigma Aldrich, MO, USA). The
emerging iPSC colonies were selected and transfered to new culture
plates covered by fresh iHFF feeder cells.
2.2. Ethical approval
This study was approved by the Andalusian Ethics Review Board for
cellular reprogramming, according to Spanish and EU legislation.2.3. RT-PCR
Total RNA was isolated using High Pure RNA Isolation kit (Roche
Applied Science, Germany) according to the manufacturer's instructions.
The concentration and quality of isolated RNA was determined using a
ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington,
DE). Complementary DNA (cDNA) was synthesized from 1 μg of total
RNA using QuantiTect Reverse Transcription Kit (Qiagen) according to
themanufacturer's instructions. Aliquots of cDNAwereused as a template
for polymerase chain reaction (PCR) ampliﬁcation with speciﬁc primer
sets. The primers used for exogenous reprogramming factors (SeV, KOS,
Klf4, and cMyc) provided by the company, and endogenous pluripotency
markers (Oct4, Sox2, Nanog, Klf4, and cMyc) are listed in Table 1. 5 μl of
PCR products were separated on a 1.5% agarose gel and visualized by
GelRed™ Gel Stain (Biotium, CA, USA).
2.4. Immunocytochemistry
Cultured GRX-MCiPS4F-A2 cells were ﬁxed with 4% paraformal-
dehyde (PFA) in PBS buffer and then permeabilized with 0.03%
Triton-X 100 (Sigma-Aldrich) for 20 min. Next, the cells were
blocked with 3% BSA (Sigma-Aldrich) in PBS for 30 min at room
temperature (RT). After that, cells were incubated with rabbit anti-
human Oct 4 antibody (1:1000, Abcam, Cambridge, UK), mouse
anti-human Tra-1-60 (1:200, Merck Millipore), or SSEA4 (1:200,
Fig. 2. In vitro and in vivo potential differentiation of GRX-MCiPS4F-A2 line. (A) Embryonic bodies (EBs) of GRX-MCiPS4F-A2were grown for 24 days and demonstrated the differentiation
into ectoderm (ßIII-tubulin), mesoderm (Vimentin), and endoderm (Ctokeratin AE1/AE3) by immunohistochemistry in vitro. (B) Hematoxylin and eosin (HE) stains show neural tube-
like, adipose-like, and gut-like epithelium structures by teratoma formation in vivo.
339S. Cabrera et al. / Stem Cell Research 15 (2015) 337–340Abcam) for 2 h at RT and then Alexa Fluor® 488 donkey anti-rabbit
IgG (1:500, Life Technology, CA, USA) or Alexa Fluor® 555 goat anti-
mouse IgG (1:500, Biomol S.L, Madrid, Spain) as a secondary anti-
body for 1 h at RT. Cells were examined using a confocal microscope
(Nikon, Yokohama, Japan) equipped with Zeiss LSM 710 (Zeiss, Jena,
Germany) using Axio Imager (Zeiss).2.5. Flow cytometry analysis
Expression of pluripotency-associated markers was determined by
ﬂow cytometry using Alexa Fluor® 647 Mouse anti-SSEA-4 (1:100),
Anti-Human TRA-1-60 Podocalyxin (1:100) and Alexa Fluor® 647
Mouse anti-Human TRA-1-81 (1:100). An irrelevant isotype-match anti-
body was always used. GRX-MCiPS4F-A2 colonies were washed with PBS
and were incubated for 5 min with TrypLE Express (Life Technologies,
CA, USA). Tripsin-dissociated cells were suspended in 3%FBS in PBS at a
concentration of 1–2× 105 cells per 100 μL and incubatedwith the specif-
ic primary antibody for 1 h at 4 °C. After washing with 3%FBS in PBS, cells
were stained with 7-aminoactinomycin D (7-AAD) (BD Bioscience) for
5 min at RT. Stained cells were analyzed using a FACSCanto (BD Biosci-
ence) and FACSDiva™ software program (BD Bioscience).2.6. Karyotype analysis
Chromosomal G-band analyses were performed at the Andalusian
Public Health System Biobank, Spain. The studywas conducted accordingTable 1
Primer sets used to amplify endogenous pluripotent genes by reverse transcription-polymeras
Gene 5′ primer sequence 3′ primer seq
Endogenous pluripotent markers
hOct4 GACAGGGGGAGGGGAGGAGCTAGG CTTCCCTCCAA
hSox2 GGGAAATGGGAGGGGTGCAAAAGAGG TTGCGTGAGT
hKlf4 ACGATCGTGGCCCCGGAAAAGGACC TGATTGTAGT
hNanog CAGCCCCGATTCTTCCACCAGTCCC CGGAAGATTCto the recommendations published by the International System Cytoge-
netics Nomenclature.
2.7. In vitro differentiation of human iPSCs
Embryoid bodies (EBs) were generated from colonies of GRX-
MCiPS4F-A2 grown in feeder-free cultures. To make EBs, 1 ml of 1:6 di-
luted Matrigel was added into iPSC cultures one day before. The iPSCs
colonies were harvested using 2 mg/ml Collagenase IV and moved to
Ultra-low attachmentmultiwell plate (Sigma-aldrich). Embryoid bodies
were grown in human iPSC medium without FGF2 to induce spontane-
ous differentiation for 24 days. Potential differentiation of EBs was ex-
amined into three germ-layers.
2.8. In vivo teratoma formation assay by human iPSCs
GRX-MCiPS4F-A2 cellswere grown in feeder-free culture and dissoci-
ated by collagenase IV treatment into single cell suspensions. Dissociat-
ed single cell pellets were re-suspended in 20 μl PBS containing 2 × 105
cells and injected subcutaneously into dorsal ﬂanks of SCID mice
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ). Teratomas were formed around
1 month after transplantations; teratomas were collected after 2
months and ﬁxed in 10% formalin. Then ﬁxed samples were processed
for parafﬁn embedding and H&E staining using standard procedures
(Gropp et al., 2012). Animal care and experimental procedures for gen-
eration of teratomas were approved by the Animal Experimentation
Ethics Committee of the University of Granada, Spain.e chain reaction (RT-PCR).
uence Annealing temp. (°C) Size (bp)
CCAGTTGCCCCAAAC 56 144
GTGGATGGGATTGGTG 56 151
GCTTTCTGGCTGGGCTCC 56 397
CCAGTCGGGTTCACC 56 343
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